Status:
COMPLETED
Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa
Lead Sponsor:
Bayer
Conditions:
Acne Vulgaris
Eligibility:
FEMALE
16-45 years
Phase:
PHASE3
Brief Summary
The purpose of the study is to determine safety and efficacy of an oral contraceptive in treating acne papulopustulosa.
Detailed Description
The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany.Bayer Schering Pharma AG, Germany is the sponsor of the trial.
Eligibility Criteria
Inclusion
- Patients with mild to moderate facial papulopustular acne
Exclusion
- Contraindication against use of hormonal contraceptives
Key Trial Info
Start Date :
March 10 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 21 2005
Estimated Enrollment :
1326 Patients enrolled
Trial Details
Trial ID
NCT00280657
Start Date
March 10 2004
End Date
May 21 2005
Last Update
June 6 2023
Active Locations (62)
Enter a location and click search to find clinical trials sorted by distance.
1
Chomutov, Czechia, 43012
2
Čáslav, Czechia, 28601
3
Kutná Hora, Czechia, 28401
4
Louny, Czechia, 44001